Artiva Biotherapeutics

Artiva Biotherapeutics

NK cell therapy for cancer patients. Learn more

Launch date
Employees
Market cap
AUD374m
Enterprise valuation
AUD326m (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...